These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7921757)

  • 1. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis.
    Veale DJ; Torley HI; Richards IM; O'Dowd A; Fitzsimons C; Belch JJ; Sturrock RD
    Br J Rheumatol; 1994 Oct; 33(10):954-8. PubMed ID: 7921757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study.
    Belch JJ; Ansell D; Madhok R; O'Dowd A; Sturrock RD
    Ann Rheum Dis; 1988 Feb; 47(2):96-104. PubMed ID: 2833184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of dietary marine oil (Polepa) and evening primrose oil (Efamol) on prostaglandin production by the rat mesenteric vasculature.
    Nassar BA; Manku MS; Huang YS; Jenkins DK; Horrobin DF
    Prostaglandins Leukot Med; 1987 Mar; 26(3):253-63. PubMed ID: 3033691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of randomized, placebo-controlled clinical trials of Efamol evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries?
    Morse NL; Clough PM
    Curr Pharm Biotechnol; 2006 Dec; 7(6):503-24. PubMed ID: 17168667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins.
    Schalin-Karrila M; Mattila L; Jansen CT; Uotila P
    Br J Dermatol; 1987 Jul; 117(1):11-9. PubMed ID: 3307886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different ratios of dietary N-6 and N-3 fatty acids on fatty acid composition, prostaglandin formation and platelet aggregation in the rat.
    Takahashi R; Nassar BA; Huang YS; Begin ME; Horrobin DF
    Thromb Res; 1987 Jul; 47(2):135-46. PubMed ID: 3660347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs.
    Brzeski M; Madhok R; Capell HA
    Br J Rheumatol; 1991 Oct; 30(5):370-2. PubMed ID: 1913008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evening primrose oil and marine oil in the treatment of psoriasis.
    Oliwiecki S; Burton JL
    Clin Exp Dermatol; 1994 Mar; 19(2):127-9. PubMed ID: 8050140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of dietary intervention with essential fatty acids in patients with categorized cysts.
    Mansel RE; Harrison BJ; Melhuish J; Sheridan W; Pye JK; Pritchard G; Maddox PR; Webster DJ; Hughes LE
    Ann N Y Acad Sci; 1990; 586():288-94. PubMed ID: 2192634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis.
    Berth-Jones J; Graham-Brown RA
    Lancet; 1993 Jun; 341(8860):1557-60. PubMed ID: 8099640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels.
    Arisaka M; Arisaka O; Yamashiro Y
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):197-201. PubMed ID: 1871184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with primary Sjögren's syndrome treated for two months with evening primrose oil.
    Oxholm P; Manthorpe R; Prause JU; Horrobin D
    Scand J Rheumatol; 1986; 15(2):103-8. PubMed ID: 3529370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial.
    Kristensen S; Schmidt EB; Schlemmer A; Rasmussen C; Johansen MB; Christensen JH
    Scand J Rheumatol; 2018 Jan; 47(1):27-36. PubMed ID: 28303758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of evening primrose seed oil in atopic asthma.
    Ebden P; Bevan C; Banks J; Fennerty A; Walters EH
    Prostaglandins Leukot Essent Fatty Acids; 1989 Feb; 35(2):69-72. PubMed ID: 2717651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).
    Nash P; Ohson K; Walsh J; Delev N; Nguyen D; Teng L; Gómez-Reino JJ; Aelion JA;
    Ann Rheum Dis; 2018 May; 77(5):690-698. PubMed ID: 29343507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results.
    Whitaker DK; Cilliers J; de Beer C
    Dermatology; 1996; 193(2):115-20. PubMed ID: 8884146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats.
    Cameron NE; Cotter MA; Robertson S
    Diabetes; 1991 May; 40(5):532-9. PubMed ID: 2022301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients.
    Yoshimoto-Furuie K; Yoshimoto K; Tanaka T; Saima S; Kikuchi Y; Shay J; Horrobin DF; Echizen H
    Nephron; 1999 Feb; 81(2):151-9. PubMed ID: 9933750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
    Edwards CJ; Blanco FJ; Crowley J; Birbara CA; Jaworski J; Aelion J; Stevens RM; Vessey A; Zhan X; Bird P
    Ann Rheum Dis; 2016 Jun; 75(6):1065-73. PubMed ID: 26792812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.